All Relations between ci and lumbar

Publication Sentence Publish Date Extraction Date Species
Chris Barnes, Fiona Newall, Vera Ignjatovic, Patricia Wong, Fergus Cameron, Graeme Jones, Paul Monagl. Reduced bone density in children on long-term warfarin. Pediatric research. vol 57. issue 4. 2005-09-20. PMID:15695604. there was a marked reduction in bone mineral apparent density of lumbar spine between patients and controls [patients 0.10 g/cm3; 95% confidence interval (ci), 0.93-0.11 g/cm3, controls 0.12 g/cm3; 95% ci, 0.11-0.12 g/cm3, p<0.001). 2005-09-20 2023-08-12 Not clear
Chris Barnes, Fiona Newall, Vera Ignjatovic, Patricia Wong, Fergus Cameron, Graeme Jones, Paul Monagl. Reduced bone density in children on long-term warfarin. Pediatric research. vol 57. issue 4. 2005-09-20. PMID:15695604. the lumbar spine areal bone mineral density z-score of patients was reduced compared with controls [patients, -1.96 (95% ci, -2.52 to -1.40). 2005-09-20 2023-08-12 Not clear
Anna M Sawka, Lehana Thabane, Alexandra Papaioannou, Amiram Gafni, David A Hanley, Jonathan D Adach. A systematic review of the effect of alendronate on bone mineral density in men. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. vol 8. issue 1. 2005-07-15. PMID:15722581. the pooled estimates of changes in bmd with 10 mg of alendronate daily compared to controls were as follows: 7.8% over 2-3 yr (95% confidence interval [ci] = 4.8- 10.8) at the lumbar spine and 3.8% (95% ci = 2.3-5.3) at the femoral neck (p < 0.001 for treatment effect in each analysis). 2005-07-15 2023-08-12 Not clear
Pilar Orozc. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. European journal of epidemiology. vol 19. issue 12. 2005-04-12. PMID:15678790. hypercholesterolemia group had higher prevalence of low-bmd at lumbar spine (82.6% vs. 55.2%, p = 0.04, or: 3.8; 95% ci: 1.04-14.2) and femoral neck (65.2% vs. 37.9%, p = 0.05, or: 3.1; 95% ci: 0.98-9.6). 2005-04-12 2023-08-12 Not clear
Pilar Orozc. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. European journal of epidemiology. vol 19. issue 12. 2005-04-12. PMID:15678790. the high-ldlc group had also higher prevalence low-bmd at femoral neck (75% vs. 39%, p = 0.01, or: 4.7; 95% ci: 1.26-17.5), and the high-lp (a) group at lumbar spine (87% vs. 51.7% p = 0.007, or: 6.2; 95% ci: 1.5-25.6). 2005-04-12 2023-08-12 Not clear
Pilar Orozc. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. European journal of epidemiology. vol 19. issue 12. 2005-04-12. PMID:15678790. women with hyperlipidemia had higher prevalence of low bmd at lumbar spine (81.8% vs. 42.1%, p = 0.003, or: 6.2; 95% ci: 1.7-22) and femoral neck (60.6% vs. 31.6%, p = 0.04, or: 3.3; 95% ci: 1.01-11.0). 2005-04-12 2023-08-12 Not clear
Kirsti Uusi-Rasi, Harri Sievänen, Ari Heinonen, Pekka Kannus, Ilkka Vuor. Effect of discontinuation of alendronate treatment and exercise on bone mass and physical fitness: 15-month follow-up of a randomized, controlled trial. Bone. vol 35. issue 3. 2005-03-22. PMID:15336619. alendronate increased bone mass significantly [mean; 95% confidence interval (ci)] during the intervention at the lumbar spine (3.9%; 2.2% to 5.7%) and femoral neck (2.1%; 0.9% to 3.4%). 2005-03-22 2023-08-12 human
Nelson B Watts, Cyrus Cooper, Robert Lindsay, Richard Eastell, Michael D Manhart, Ian P Barton, Tjeerd-Pieter van Staa, Jonathan D Adach. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. vol 7. issue 3. 2004-11-16. PMID:15319494. the changes in lumbar spine bmd explained only 18% (95% confidence interval [ci], 10%, 26%; p < 0.001) of risedronate's vertebral fracture efficacy. 2004-11-16 2023-08-12 Not clear
Christian Meier, Müller Beat, Merih Guglielmetti, Mirjam Christ-Crain, Jean-Jacques Staub, Marius Kraenzli. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. vol 15. issue 3. 2004-04-22. PMID:14727010. at the end of the study, lumbar bmd in the both treatment groups differed by 1.3% (95%ci, -2.9 to 0.5) with lower levels in l-thyroxine treated women. 2004-04-22 2023-08-12 Not clear
K Uusi-Rasi, P Kannus, S Cheng, H Sievänen, M Pasanen, A Heinonen, A Nenonen, J Halleen, T Fuerst, H Genant, I Vuor. Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone. vol 33. issue 1. 2004-04-13. PMID:12919708. alendronate daily was effective in increasing bone mass at the lumbar spine (alendronate vs placebo 3.5%; 95% ci, 2.2-4.9%) and femoral neck (1.3%; 95% ci, 0.2-2.4%) but did not affect other bone sites. 2004-04-13 2023-08-12 human
V Mann, S H Ralsto. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone. vol 32. issue 6. 2004-02-27. PMID:12810179. under a fixed effects model, bmd values at the lumbar spine (6800 subjects) were significantly lower in the "ss" genotype group when compared with "ss" homozygotes (standardized mean difference = 0.131 [95% ci, 0.06,0.16], p = 0.00005) but the difference was not significant for the "ss" comparison (0.09 [-0.03,0.21], p = 0.13). 2004-02-27 2023-08-12 human
L B Tankó, M R McClung, R C Schimmer, P Mahoney, C Christianse. The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast. Bone. vol 32. issue 4. 2003-12-11. PMID:12689686. after 48 weeks of treatment, the relative increase in lumbar spine bmd from baseline in the 30-min fast group was lower than that in the 60-min fast group (3.07% versus 4.95%, one-sided 97.5% ci = -2.89%) such that the prespecified noninferiority criteria were not met. 2003-12-11 2023-08-12 human
R Rizzoli, S L Greenspan, G Bone, T J Schnitzer, N B Watts, S Adami, A J Foldes, C Roux, M A Levine, B Uebelhart, A C Santora, A Kaur, C A Peverly, J J Orlof. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. vol 17. issue 11. 2003-04-24. PMID:12412806. mean bmd increases from baseline (95% ci) at 24 months in the once-weekly, twice-weekly, and daily treatment groups, respectively, were 6.8% (6.4, 7.3), 7.0% (6.6,7.5), and 7.4% (6.9,7.8) at the lumbar spine and 4.1% (3.8,4.5), 4.3% (3.9,4.7), and 4.3% (3.9,4.7) at the total hip. 2003-04-24 2023-08-12 Not clear
John P A Ioannidis, Ioanna Stavrou, Thomas A Trikalinos, Christos Zois, Maria Luisa Brandi, Luigi Gennari, Omar Albagha, Stuart H Ralston, Agathocles Tsatsouli. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. vol 17. issue 11. 2003-04-24. PMID:12412813. the magnitude of the effect was similar in the femoral neck and lumbar spine (0.014 g/cm2 [95% ci, 0.003-0.025] and 0.015 g/cm2 [95% ci, 0.000-0.030], respectively; no between-study heterogeneity for either). 2003-04-24 2023-08-12 human
Amit N Shah, Ricardo Pietrobon, William J Richardson, Barry S Myer. Patterns of tumor spread and risk of fracture and epidural impingement in metastatic vertebrae. Journal of spinal disorders & techniques. vol 16. issue 1. 2003-04-16. PMID:12571489. fracture risk was greatest for upper lumbar (rr = 1.95; 95% ci: 1.12, 3.38) and undifferentiated tumors (rr = 7.36; 95% ci: 2.69, 20.12). 2003-04-16 2023-08-12 Not clear
S A Kontulainen, P A Kannus, M E Pasanen, H T Sievänen, A O Heinonen, P Oja, I Vuor. Does previous participation in high-impact training result in residual bone gain in growing girls? One year follow-up of a 9-month jumping intervention. International journal of sports medicine. vol 23. issue 8. 2003-03-26. PMID:12439773. the regression analysis showed that the trainees (n = 50) had 4.9 % (95 % ci, 0.9 % to 8.8 %, p = 0.017) greater bmc increase in the lumbar spine than the controls (n = 49). 2003-03-26 2023-08-12 Not clear
M R Sowers, J S Finkelstein, B Ettinger, I Bondarenko, R M Neer, J A Cauley, S Sherman, G A Greendal. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. vol 14. issue 1. 2003-03-20. PMID:12577184. serum logfsh concentrations were inversely correlated with bmd (r = -10 for lumbar spine [95% confidence interval (ci): -0.13, -0.06] and r = -0.08 for femoral neck (95% ci: -0.11, -0.05). 2003-03-20 2023-08-12 Not clear
M J Välimäki, K Laitinen, A Patronen, H Puolijoki, J Seppänen, L Pylkkänen, Suvi-Marja Aranko, Sirpa Sairanen, Harri Blåfield, Matti Rekiaro, Kari Väisänen, Martti Kormano, Lasse Mäkinen, Jorma Salmi, Kyösti Ala-Kaila, Jyrki Perttilä, Kai Vesterinen, Kalevi Koivunor. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. vol 13. issue 12. 2003-02-24. PMID:12459936. in the primary study mean changes in lumbar spine bmd were -3.4% in the placebo group and +0.4% in 800 mg clodronate group [difference between groups at 3 years 3.8% (95% ci 2.7% to 4.9%, p<0.0001)], and in the trochanter area bmd -1.1% in the placebo group, and + 0.4% in the 800 mg clodronate group [difference between groups at 3 years 1.5% (95% ci 0.05% to 2.9%)]. 2003-02-24 2023-08-12 human
M J Välimäki, K Laitinen, A Patronen, H Puolijoki, J Seppänen, L Pylkkänen, Suvi-Marja Aranko, Sirpa Sairanen, Harri Blåfield, Matti Rekiaro, Kari Väisänen, Martti Kormano, Lasse Mäkinen, Jorma Salmi, Kyösti Ala-Kaila, Jyrki Perttilä, Kai Vesterinen, Kalevi Koivunor. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. vol 13. issue 12. 2003-02-24. PMID:12459936. during the extension study mean changes in lumbar spine bmd were +1.5% in the clodronate group and -0.2 % in the placebo group [difference between groups 1.7% (ci 0.4% to 3.0%, p = 0.010)] and in trochanter bmd were +2.5% in the clodronate group and no change in the placebo group [difference between groups 2.1% (ci 0.3% to 3.9%, p = 0.007)]. 2003-02-24 2023-08-12 human
E Kanterewicz, A Yañez, A Pérez-Pons, I Codony, L Del Rio, A Díez-Pére. Association between Colles' fracture and low bone mass: age-based differences in postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. vol 13. issue 10. 2002-12-20. PMID:12378372. after adjusting for age, menopausal status and body mass index, osteoporosis and osteopenia remained significantly associated with cf only in women aged 65 years or less (ultradistal forearm or 5.7 (95% ci 1.2-27.2), lumbar spine or 3.9 (95% ci 1.1-14.3)). 2002-12-20 2023-08-12 Not clear